TRPV4 and skeletal dysplasia: Remarkably, all tested neuropathy mutations resulted in nearly complete disruption of TRPV4–RhoA interaction, whereas the skeletal dysplasia mutations displayed variably preserved interaction with RhoA (Fig. 2b–e and Supplementary Fig. 2a).